Replies to post #4063 on GTC Biotherapeutics (fka GTCB)

[bornfromapetridish]

My best guess that the delay in reimbursement rates is because the company(s) are dealing with EU bureaucracy. Never expect quick actions from the EU.

[DewDiligence]

>any idea how many countries are left to negotiate with?<

No idea. This will be a subject for discussion on the 2Q07 CC in August.